Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Revolutionizing depression treatment: Breaking free from ineffective medications for rapid relief

Hoag Memorial Hospital Presbyterian
Conditions
May 15, 2023
Share
Tweet
Share

If you want to know whether a standard-of-care medication will work to treat your depression, flip a coin.

More than half of all patients treated for major depressive disorder (MDD), the clinical name for what is typically thought of as depression, don’t respond to the first treatment option prescribed to them. Even those who do respond often won’t see the full clinical benefit for up to 12 weeks. And yet, prescribing these medications is standard practice in a field that adheres to a “start low, go slow” approach to medication therapies.

I believe that this approach is outdated and no longer serves patients, more than 50 percent of whom require multiple therapeutic approaches before finding one that works for them.

People are suffering. We can do better.

Non-pharmacologic interventions, such as electroconvulsive therapy and transcranial magnetic stimulation, work more quickly than medications, and many have longer-lasting effects. Meanwhile, clinical trials involving investigational agents such as psilocybin are showing promise, and off-label or approved use of drugs such as ketamine and esketamine are delivering fast, long-lasting results to patients for whom standard-of-care medications have not worked. The consequence of not having rapid effects on depression include the risk of suicide, not taking the right medication that could help, treatment costs, and greater disease burden.

In a paper I published recently in the journal CNS Spectrums, I noted that the most significant downside to any of these alternatives is the fact that all must be administered in a facility by trained specialists, which adds to the time to treatment.

However, the fast-acting results of these alternatives suggest that there are better, safer methods out there to help people with MDD. And discovering those better alternatives is critical.

MDD is characterized by a host of undesirable symptoms, including:

  • anhedonia or decreased interest in pleasurable activities
  • feelings of guilt or worthlessness
  • lack of energy
  • poor concentration
  • appetite changes
  • slowing down of thought and/or movement
  • sleep disturbances
  • suicidal thoughts.

Delays in symptom resolution are associated with poor outcomes and decreased quality of life. These effects are not trivial: MDD accounts for 87 percent of suicides, and MDD is one of the leading causes of disability worldwide. Meanwhile, when treatment does work soon after diagnosis, patients experience a greater likelihood of recovery. So, getting treatments that work as quickly as possible is essential.

Clearly, an unmet need exists for innovative treatments that offer rapid and sustained effects, and I’m excited by some of what I am seeing in our field. Innovative treatments are now emerging, and continued investigational work in this area will allow doctors to cater to individualized therapy that works quickly and provide the help people need when they need it.

Electroconvulsive therapy (ECT), which involves applying electrical stimulation to a patient’s brain, is an FDA-approved intervention associated with fast and sustained effects in patients with severe treatment-resistant depression. Another exciting treatment option is transcranial magnetic stimulation (TMS), also an FDA-approved, rapid-acting, non-pharmacologic therapy that treats adults for whom standard medications have failed.

Drugs with rapid and sustained effects that are now approved or used off-label include ketamine, esketamine, and dextromethorphan-bupropion, which can provide antidepressant effects as quickly as one hour after taking them – with effects sustained for up to six weeks. However, ketamine and esketamine both carry the potential for abuse, and all three require in-clinic visits for treatment.

Psychedelics, such as psilocybin, are also showing promise in clinical trials for patients whose MDD symptoms have not been relieved by standard medications.

ADVERTISEMENT

I am excited to see the therapeutic landscape for MDD shifting to better address the delay in relief patients have experienced. We are on the cusp of something powerful, meaningful, and lasting. Something that will turn the “start low, go slow” clinical approach into a more effective mindset that recognizes time is of the essence when treating depression.

It is my hope that the work being done in this field will yield therapies that target individualized treatments to provide relief quickly and effectively because MDD is debilitating, and the odds of you recovering from it should be greater than the toss of a coin.

Gus Alva is a psychiatrist, Hoag Memorial Hospital Presbyterian.

Prev

Revolutionizing health care: lessons from Michael Jordan's partnership with Nike

May 15, 2023 Kevin 0
…
Next

The unintended consequences of centralized EHR scheduling

May 15, 2023 Kevin 0
…

Tagged as: Psychiatry

Post navigation

< Previous Post
Revolutionizing health care: lessons from Michael Jordan's partnership with Nike
Next Post >
The unintended consequences of centralized EHR scheduling

ADVERTISEMENT

More by Hoag Memorial Hospital Presbyterian

  • Why male fertility needs to be part of every health conversation

    Hoag Memorial Hospital Presbyterian
  • Cancer treatment and sexual health: the conversation we need to have

    Hoag Memorial Hospital Presbyterian
  • How AI is transforming breast cancer detection: a game-changing tool for early diagnosis and personalized care

    Hoag Memorial Hospital Presbyterian

Related Posts

  • Treating depression with ketamine: We need incremental treatment for depression

    Shaili Jain, MD
  • The ritual of taking medications: the pill wheel

    Fery Pashang, PharmD
  • The tip of the iatrogenic benzodiazepine iceberg

    Nicole Lamberson, PA
  • Stop stigmatizing medication-assisted treatment

    Brandon Jacobi
  • Sleep and the medical profession have an uneasy relationship

    Yoo Jung Kim, MD
  • Medical school and the science of sleep

    Sarah Murad

More in Conditions

  • Addressing menstrual health inequities in adolescents

    Callia Georgoulis
  • Healing beyond the surface: Why proper chronic wound care matters

    Alvin May, MD
  • Why specialist pain clinics and addiction treatment services require strong primary care

    Olumuyiwa Bamgbade, MD
  • What a childhood stroke taught me about the future of neurosurgery and the promise of vagus nerve stimulation

    William J. Bannon IV
  • Facing terminal cancer as a doctor and mother

    Kelly Curtin-Hallinan, DO
  • Why doctors must stop ignoring unintentional weight loss in patients with obesity

    Samantha Malley, FNP-C
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • How Project ECHO is fighting physician isolation and transforming medical education [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why clinical research is a powerful path for unmatched IMGs

      Dr. Khutaija Noor | Education
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • FDA delays could end vital treatment for rare disease patients

      GJ van Londen, MD | Meds
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • How Project ECHO is fighting physician isolation and transforming medical education [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why clinical research is a powerful path for unmatched IMGs

      Dr. Khutaija Noor | Education
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
    • How to advance workforce development through research mentorship and evidence-based management

      Olumuyiwa Bamgbade, MD | Physician
    • The truth about perfection and identity in health care

      Ryan Nadelson, MD | Physician
    • Civil discourse as a leadership competency: the case for curiosity in medicine

      All Levels Leadership | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...